临床病理学特征和长期结局在半月形成的球炎:一个20年的单中心队列研究研究
Tugay Yılmaz1, Hüseyin Döngelli1, Mehmet Ası Oktan2
1Department of Internal Medicine, Dokuz Eylul University Hospital, Izmir, Turkiye.
Acta clinica Belgica
|February 18, 2026
概括
单疗法在新月状丸炎 (GN) 患者与末期病 (ESKD) 和死亡率的风险更高有关. 不充分的免疫抑制可能会使这些侵袭性病的结果变得更糟.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 半月状丸炎 (GN) 是一种严重的病,其特征是功能迅速下降.
- 识别预测不良结果的因素对于管理半月性GN患者至关重要.
研究的目的:
- 确定临床,实验室和基因病学预测器的末期病 (ESKD) 和整体存活率 (OS) 在半月GN的患者.
- 识别与新月式GN中不利结果相关的因素.
主要方法:
- 194名接受脏活检的成年患者的回顾性队列研究 (2005-2024年).
- 主要终点:进展到ESKD和OS.
- 统计分析包括考克斯比例危险和卡普兰-梅尔方法.
主要成果:
- 免疫复合体GN是最常见的亚型 (59.3%).
- 42.8%的患者进展为ESKD,35.6%在随访期间死亡.
- 维护类固醇单疗独立预测ESKD (HR 2.349) 和死亡率 (HR 2.427),以及基线肌素,蛋白尿,血球硬化,IgA阳性,年龄较大和降低的eGFR.
结论:
- 维护性类固醇单疗法是ESKD和新月性GN的死亡率的重要风险因素.
- 这些发现强调了适当的免疫抑制在高风险的半月GN患者的重要性.
相关概念视频
Acute Kidney Injury III: Clinical Manifestations
1.0K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K
Acute Pyelonephritis II: Diagnostic Studies and Management
481
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
481
Nephrotic Syndrome I : Introduction
712
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
712
Acute Pyelonephritis I: Introduction
792
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
792
Acute Kidney Injury II: Pathophysiology
1.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
Nephrotic Syndrome II : Assessment and Medical Management
263
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
263


